4D Molecular Therapeutics Inc (FDMT)

Working Capital Ratio

68.06%

Quarterly · Period ending:

FDMT logo

FDMT Working Capital Ratio

Latest reported68.06%
FDMT Quarterly Working Capital Ratio (88.70% → 68.06%)
High-resolution chart · PNG

FDMT working capital ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

4D Molecular Therapeutics Inc Working Capital Ratio — Quarterly
Period endingWorking Capital Ratio
68.0621%
70.5706%
65.1388%
64.9249%
56.7122%
59.2689%
72.4116%
79.6804%
85.9886%
82.4257%
81.6841%
85.7491%
86.2481%
80.2234%
78.2063%
78.1378%
76.6472%
71.0796%
67.8786%
64.1515%
93.7035%
92.7701%
92.2246%
79.699%
67.9208%
83.0335%
83.0335%
88.7026%
88.7026%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.